298380 Stock Chart & Stats
₩72400.00
-₩1,900.00(-2.56%)
―
--
Day’s Range― - ―
52-Week Range₩67,100.00 - ₩257,500.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)411.88K
Market Cap
₩4.05T
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.45
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding55,987,465
10 Day Avg. Volume336,908
30 Day Avg. Volume411,885
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-12,758,198.73
Revenue Forecast (FY)₩10.00T>
298380 FAQ
What was ABL Bio, Inc.’s price range in the past 12 months?
ABL Bio, Inc. lowest stock price was ₩67100.00 and its highest was ₩257500.00 in the past 12 months.
What is ABL Bio, Inc.’s market cap?
ABL Bio, Inc.’s market cap is ₩4.05T.
When is ABL Bio, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ABL Bio, Inc.’s earnings last quarter?
Currently, no data Available
Is ABL Bio, Inc. overvalued?
According to Wall Street analysts ABL Bio, Inc.’s price is currently Undervalued.
Does ABL Bio, Inc. pay dividends?
ABL Bio, Inc. does not currently pay dividends.
What is ABL Bio, Inc.’s EPS estimate?
ABL Bio, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ABL Bio, Inc. have?
ABL Bio, Inc. has 55,987,465 shares outstanding.
What happened to ABL Bio, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ABL Bio, Inc.?
Currently, no hedge funds are holding shares in KR:298380
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hanall Biopharma Co., Ltd.
―
HLB Co., Ltd.
―
Celltrion Pharm Inc.
―
OliX Pharmaceuticals, Inc.
―
Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh
―